Boothbay Fund Management, LLC Evolus, Inc. Transaction History

Boothbay Fund Management, LLC

$3.27 Billion
Q4 2024

A detailed history of Boothbay Fund Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 1,287,767 shares of EOLS stock, worth $18 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

1,287,767

Previous 983,702 30.91%

Holding current value

$18 Million

Previous $15.9 Million 10.79%

% of portfolio

0.43%

Previous 0.44%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.84 - $17.45 $3.3 Million - $5.31 Million	304,065 Added 30.91%	1,287,767 $14.2 Million
Q3 2024 Nov 14, 2024	SELL	$10.66 - $17.48 $136,533 - $223,883	-12,808 Reduced 1.29%	983,702 $15.9 Million
Q2 2024 Aug 14, 2024	BUY	$10.45 - $13.76 $244,613 - $322,094	23,408 Added 2.41%	996,510 $10.8 Million
Q1 2024 May 15, 2024	BUY	$9.99 - $14.91 $1.36 Million - $2.03 Million	136,177 Added 16.27%	973,102 $13.6 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $2.48 Million - $3.43 Million	-325,980 Reduced 28.03%	836,925 $8.81 Million
Q3 2023 Nov 14, 2023	SELL	$7.15 - $10.2 $1.02 Million - $1.46 Million	-143,136 Reduced 10.96%	1,162,905 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $1.44 Million - $2.1 Million	199,592 Added 18.04%	1,306,041 $9.49 Million
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $196,335 - $277,785	25,139 Added 2.32%	1,106,449 $9.36 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $1.01 Million - $1.39 Million	155,114 Added 16.75%	1,081,310 $8.12 Million
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $372,782 - $659,095	-48,039 Reduced 4.93%	926,196 $7.46 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $7.28 Million - $9.93 Million	712,370 Added 272.04%	974,235 $11.3 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $788,512 - $1.78 Million	151,056 Added 136.32%	261,865 $2.94 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $680,411 - $1.13 Million	80,809 Added 269.36%	110,809 $1.4 Million
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $96,000 - $495,300	30,000 New	30,000 $390,000
Q1 2020 May 15, 2020	SELL	$3.53 - $12.21 $38,830 - $134,310	-11,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.58 - $17.37 $127,380 - $191,070	11,000 New	11,000 $134,000

Others Institutions Holding EOLS

# of Institutions

169

Shares Held

48.8M

Call Options Held

57.2K

Put Options Held

5.5K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $785M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account

Boothbay Fund Management, LLC Evolus, Inc. Transaction History